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Abstract Craniofacial morphogenesis requires proper development of pharyngeal arches and
epibranchial placodes. We show that the epibranchial placodes, in addition to giving rise to cranial
sensory neurons, generate a novel lineage-related non-neuronal cell population for mouse
pharyngeal arch development. Eya1 is essential for the development of epibranchial placodes and
proximal pharyngeal arches. We identify an Eya1-Notch regulatory axis that specifies both the
neuronal and non-neuronal commitment of the epibranchial placode, where Notch acts
downstream of Eya1 and promotes the non-neuronal cell fate. Notch is regulated by the threonine
phosphatase activity of Eya1. Eya1 dephosphorylates p-threonine-2122 of the Notch1 intracellular
domain (Notch1 ICD), which increases the stability of Notch1 ICD and maintains Notch signaling
activity in the non-neuronal epibranchial placodal cells. Our data unveil a more complex
differentiation program in epibranchial placodes and an important role for the Eya1-Notch axis in
craniofacial morphogenesis.
DOI: https://doi.org/10.7554/eLife.30126.001
Introduction
Craniofacial morphogenesis depends on integration of signals from multiple cell types and is a com-
plex morphogenetic process requiring, among other structures, the genesis of cranial placodes and
pharyngeal arches. The cranial placodes are ectodermal thickening structures derived from the pre-
placodal primordium, an ectodermal region adjacent to the neural plate (Baker and Bronner-Fraser,
2001). The cranial placodes are divided into the anterior (adenohypophyseal, olfactory and lens plac-
odes), intermediate (trigeminal placode) and posterior placodes (otic, lateral line and epibranchial
placodes) (Streit, 2007; Saint-Jeannet and Moody, 2014; Singh and Groves, 2016) (Figure 1A).
The epibranchial placodes comprise the geniculate, petrosal and nodose placodes, which contribute
to the cranial nerve VII (facial), IX (glossopharyngeal) and X (vagus), respectively (D’Amico-
Martel and Noden, 1983). It is believed that the principle function of the epibranchial placodes is
to produce viscero-sensory neurons by delaminating cells that undergo neuronal differentiation
(Narayanan and Narayanan, 1980). In contrast, the olfactory and otic placodes also generate non-
neuronal secretory or supporting cells, in addition to delaminating neuronal cells (Patthey et al.,
2014). The pharyngeal arches (PA) are transient structures formed in the pharyngeal region of the
early embryonic head and interactions of the pharyngeal epithelium, the endoderm, neural crest and
mesenchyme give rise to facial, head and neck structures during development (Figure 1A). A key
aspect of PA formation is the segmentation process, during which the pharyngeal endoderm
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extends laterally towards the ectoderm, forming an epithelial pocket called the pharyngeal pouch,
while the surface ectoderm invaginates and forms the pharyngeal cleft (Graham, 2003). The contact
between ectodermal cleft and endodermal pouch forms the segmental plate, which gradually
extends proximal-distally to define the boundary between each PA, and restricts the route for neural
crest migration into each arch (Graham et al., 2005; Shone and Graham, 2014). The segmental
contact points are also sources of signaling factors that regulate the anterior-posterior and proximal-
distal patterning of the PA and promote mesenchymal cell survival (Trumpp et al., 1999;
Couly et al., 2002; David et al., 2002). The relationship between epibranchial placodes and PA
development is poorly understood, but the notion that the geniculate, petrosal and nodose placo-
des are located near the pharyngeal clefts (Figure 1A), suggests that they are part of the coordi-
nated development of the corresponding PA.
Eya and Six transcription factors are highly evolutionarily conserved and among the first factors
expressed across the pre-placodal region where they are critical regulators of placodal cell differenti-
ation in later stages (Kozlowski et al., 2005; Chen et al., 1997; Pandur and Moody, 2000;
Christophorou et al., 2009; Zou et al., 2004; Saint-Jeannet and Moody, 2014). Six proteins are
DNA-binding activator proteins that promote expression of pre-placodal genes when partnered with
Eya. In contrast, Eya does not bind DNA directly, but acts as the transactivating partner to Six pro-
teins. The importance of Eya and Six proteins for craniofacial development is underscored by that
mutations in the human EYA1 and SIX genes, including SIX1 and SIX5, are reported in approximately
50% of the patients suffering from Branchio-Oto-Renal (BOR) syndrome (Abdelhak et al., 1997;
Smith, 1993). Eya1 mutant mouse embryos display phenotypes in multiple pharyngeal and placodal
derivatives including cranial neural crest cell-derived bones and cartilages, endoderm-derived tym-
panic cavity, thymus, thyroid and parathyroid glands, ectoderm-derived external auditory canal, otic
and epibranchial placodes (Xu et al., 1999, 2002; Zou et al., 2004, 2006). Six1-/- and Six4-/- mouse
embryos also exhibit pharyngeal phenotypes along with kidney problems (Laclef et al., 2003;
Zou et al., 2006), in keeping with a tight functional coupling between Eya and Six proteins. How-
ever, the Eya1 protein does not only serve as a transcriptional co-activator, but also possesses tyro-
sine and threonine phosphatase activities (Li et al., 2003; Okabe et al., 2009; Tadjuidje and
Hegde, 2013). The tyrosine phosphatase activity of Eya1 regulates H2AX and DNA repair
(Cook et al., 2009) and is also required for the function of Eya1 as a transactivator in conjunction
with Six (Li et al., 2003). Less is known about the threonine phosphatase activity, but dephosphory-
lation of T58 in c-Myc by Eya1 has been shown to be important for nephrogenesis and tumour
growth (Xu et al., 2014; Li et al., 2017).
Craniofacial development is regulated by Notch signalling. Genetic and pharmacological inhibi-
tion of Notch results in proximal PA and craniofacial defects as well as premature neurogenesis and
neuronal delamination (Humphreys et al., 2012; Zuniga et al., 2010; Daudet and Lewis, 2005;
de la Pompa et al., 1997; Lassiter et al., 2010; Lassiter et al., 2014). Conversely, activation of
Notch in the cranial placodes prevents both neurogenesis and delamination and expands the placo-
dal epithelium (Jayasena et al., 2008; Pan et al., 2013). The Notch signalling pathway is an evolu-
tionarily ancient cell-cell communication system that controls differentiation in most tissues and
organs. Upon activation by ligand on a juxtaposed cell, the Notch receptor is proteolytically proc-
essed and the final cleavage, which is executed by the g-secretase complex, liberates the C-terminal
portion of the Notch receptor, the Notch intracellular domain (Notch ICD). Notch ICD is translocated
into the nucleus to form a complex with the DNA-binding protein CSL, which converts CSL from a
repressor to an activator, leading to activation of Notch downstream genes, including Hes and Hey
genes (Siebel and Lendahl, 2017). Notch gene dosage and the level of Notch receptor mediated
signaling have profound impact on cell fate decision in many cell types during development
(Andersson and Lendahl, 2014).
Here we address novel roles of Eya1 in regulating PA and epibranchial placode differentiation.
We show that Eya1 is required for proper proximal PA, pharyngeal cleft and pouch formation. We
also provide evidence that epibranchial placodes are not limited to generating viscero-sensory neu-
rons only, but contain bipotential epithelial progenitors that in addition produce a non-neuronal cell
lineage important for PA development. We further identified Notch1 ICD as a novel target of the
threonine phosphatase activity of Eya1. Dephosphorylation leads to stabilization of Notch1 ICD and
enhanced Notch signaling. Our data provide evidence for a more complex composition of epibran-
chial placodes and an Eya1-Notch axis important for PA formation and craniofacial morphogenesis.
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Figure 1. Cranial placode and pharyngeal arch development in wildtype and Eya1-/- mouse embryos. (A) Schematic summary of the development of
cranial placodes and pharyngeal arches (PA) in mouse embryos. The pre-placodal region, marked by expression of Eya and Six families of genes at
E8.0, is divided into anterior, medial and posterior placodal regions at E8.5, which further develops into specific cranial placodes (A, adenohypophyseal;
O, olfactory; L, lens; T, trigeminal; Gen, geniculate; Pet, petrosal; Nod, nodose) from E8.5–9.5. The epibranchial placodes are located in close proximity
Figure 1 continued on next page
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Results
Eya1-/- embryos exhibit defective pharyngeal arch segmentation and
lack proximal arch structures
The first PA became morphologically identifiable at E8.5, at this stage wildtype and mutant PA
appeared grossly comparable in size and morphology (data not shown). In contrast, at E9.5, Eya1-/-
embryos showed hypoplastic second and third PA with barely visible pharyngeal clefts (Figure 1B
and C). E-cadherin immunostaining, which labeled the ectodermal and endodermal epithelia,
revealed that the pharyngeal segmental plates were not formed. There were no contact points
between the pharyngeal ectoderm and endoderm-derived epithelia, such that the pharyngeal clefts
and pouches could not form properly and the pharyngeal mesenchyme in adjacent PA never sepa-
rated (Figure 1D and E).
In E10 Eya1-/- embryos the PA2 was shortened, with an apparent reduction of the proximal por-
tion, while the distal part was still present (Figure 1H and I). To assess this further, we performed in
situ hybridization with three markers that have distinct expression patterns along the proximal-distal
axis: Dlx1 (expressed in both the proximal and distal parts), Dlx5 (expressed only in the distal part)
and Brn1 (Pou3f3; expressed only in the proximal part) (Jeong et al., 2008). At E9.5, Dlx1 expres-
sion was lost in the Eya1-/- embryos in the proximal portion of the PA, but retained in the distal
arches (Figure 1J and K). Dlx5 was expressed in the distal region in both wildtype and Eya1-/-
embryos (Figure 1L and M), whereas Brn1 expression was lost in proximal PA2 in Eya1-/- embryos
but expressed in the maxillary-mandibular junction of PA1 and proximal region of PA2 in wildtype
(Figure 1N and O). We examined the expression of the neural crest marker gene Crabp1 and con-
firmed that the migrating neural crest stream in the PA2 was reduced in the Eya1-/- embryos
(Figure 1F and G). TUNEL analysis revealed that the Eya1-/- embryos displayed increased cell death
at the dorsal level around the entrances of PA1 and PA2 (Figure 1—figure supplement 1A–1E).
Taken together, the analysis of the Eya1-/- phenotype shows that the abnormal pharyngeal arch seg-
mentation and proximal PA defects are likely the basis for the abnormal morphogenesis in Eya1-/-
embryos previously described (Xu et al., 1999).
Eya1-/- specific phenotypes in the pharyngeal arch and epibranchial
placode
Eya1 and Six1 are both important for craniofacial morphogenesis (Xu et al., 1999; Laclef et al.,
2003; Zou et al., 2006) and we first compared their expression patterns. At E8.5 and before the
pharyngeal arch outgrowth, Eya1 was expressed broadly in the posterior placode and the pharyn-
geal region, including the pharyngeal ectoderm and pharyngeal pouch (Figure 2A and A’). At E9.5,
Eya1 was restricted to the maxillary and most distal part of PA1, the proximal-rostral and caudal
parts of PA2, and the posterior PA (Figure 2B and B’). Eya1 immunoreactivity was observed in both
Figure 1 continued
to the pharyngeal segmental plates (circled with black dotted lines). The grey dashed line indicates the plane of coronal section, which reveals the
pharyngeal segmental plates and arch structures as shown in the diagram on the right (also panel D and E). The PA structures include the pharyngeal
ectoderm (red), endoderm (blue) and the transient pharyngeal segmental plates, which form the clefts and pouches. The neural crest, mesoderm and
aortic arch arteries are indicated in purple, green and white, respectively. (B and C) Lateral view of wildtype (WT) and Eya1-/- whole mount E9.5
embryos. Open arrowheads indicate positions of pharyngeal clefts; PA1 and PA2 are numbered (n > 20). (D and E) Immunostaining for E-cadherin
(green) and DAPI (blue) on coronal sections of WT and Eya1-/- E9.5 embryos. Arrowheads indicate positions of the pharyngeal segmental plates, which
are not formed in Eya1-/- embryos (n = 4). (F and G) Whole-mount in situ hybridization showing Crabp1 expression in WT and Eya1-/- E9.5 embryos
(n = 5). (H and I) Scanning electron microscopy images of WT and Eya1-/- embryos at E10. White bracket in WT embryo indicates the proximal region of
PA2, which was missing in Eya1-/- embryos (indicated by arrow) (n = 5). (J–O) Expression of Dlx1, Dlx5 and Brn1 in WT and Eya1-/- E9.5 embryos. White
brackets indicate the proximal region of PA2 in WT embryos. Arrows indicate the missing proximal PA2 in Eya1-/- embryos (n > 5). Scale bars, 100 mm.
DOI: https://doi.org/10.7554/eLife.30126.002
The following source data and figure supplement are available for figure 1:
Source data 1. Source data relating to Figure 1—figure supplement 1E.
DOI: https://doi.org/10.7554/eLife.30126.004
Figure supplement 1. TUNEL assay in WT and Eya1-/- E9.5 embryos.
DOI: https://doi.org/10.7554/eLife.30126.003
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cytoplasm and nucleus in ectodermal cells (Figure 2—figure supplement 1A and A’). The expres-
sion pattern of Six1 was similar to Eya1 at E9.5 (Figure 2C), although Six1 expression also extended
into the pharyngeal ectomesenchyme (Figure 2C’).
Sox3-/- and Fgfr1n7/n7 mutants display similar proximal pharyngeal arch phenotypes
(Trokovic et al., 2003; Rizzoti and Lovell-Badge, 2007) and we therefore analyzed the expression
of SoxB1 genes and Fgf signaling factors in Eya1-/- and Six1-/- E9.5 embryos. Analysis of Sox2, which
is an early marker for cranial placodes (Wood and Episkopou, 1999), revealed expression in the ros-
tral-proximal part of the pharyngeal ectoderm (Figure 2J and J’) and a reduction of Sox2 expression
in both Six1 and Eya1 knockout embryos (Figure 2K and L). However, Sox2+ cells were still
observed in the pharyngeal ectoderm in both mutants (Figure 2D–2F). In Eya1-/- embryos, Sox2+
Figure 2. Differences in pharyngeal arch phenotypes in Eya1-/- and Six1-/- embryos. (A–C’) In situ hybridization on whole-mount and coronal sections of
Eya1 and Six1 in WT embryos at E8.5 (n = 5) and E9.5 (n = 5). (D–I) Immunostaining for Sox2 and Sox3 on coronal sections of E9.5 WT, Eya1-/- and
Six1-/- embryos. (J–R’) In situ hybridization of Sox2, Fgf3, and Spry1 on whole-mount and coronal sections of E9.5 embryos (n  5). (S–U’) In situ
hybridization of Neurog2 on whole-mount and coronal sections through the region of the geniculate and petrosal placodes of E9.5 embryos (n = 5). (V)
Schematic summary of the abnormal PA phenotype and gene expression patterns in WT, Eya1-/- and Six1-/- embryos. Light blue and light orange label
the Brn1+ proximal and Dlx5+ distal PA regions, respectively. The black dotted circles demarcate the pharyngeal segmentation plates. Green, blue, and
red indicate Sox2+ and Fgf3+, single Sox2+ and Neurog2+ expression regions, respectively. em, ectomesenchyme; g, geniculate placode; p, petrosal
placode; n, nodose placodes. Arrowheads indicate rostral-proximal ectodermal cells of PA2. Scale bars, 100 mm.
DOI: https://doi.org/10.7554/eLife.30126.005
The following figure supplement is available for figure 2:
Figure supplement 1. Expression of Eya1, Fgf8, Fgf15, and Fgfr1 in the pharyngeal ectoderm of E9.5 embryos.
DOI: https://doi.org/10.7554/eLife.30126.006
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cells were found in the residual proximal pharyngeal ectoderm, and the total number of Sox2+ cells
in the mutant geniculate placode (139 ± 33, n = 3) was significantly reduced compared with wildtype
(286 ± 26, n = 3). Expression of Sox3, which also regulates pharyngeal segmentation and proximal
PA2 development (Rizzoti and Lovell-Badge, 2007), was reduced in Eya1-/- (Figure 2H) but unaf-
fected in Six1-/- ectoderm (Figure 2I).
In wildtype and Six1-/- E9.5 embryos, Fgf3 expression was observed in the rostral-proximal pha-
ryngeal ectoderm and endoderm (Figure 2M, M, O and O’). While Fgf3 expression in the pharyn-
geal endoderm was retained in the Eya1-/- embryos (Figure 2N’), Fgf3 expression was dramatically
reduced in the Sox2+ epithelial cells (Figure 2N and N’). Fgf3 expression stems from Sox2+ cells
(see below), and the fact that these cells were still present in the Eya1-/- embryos (Figure 2E) indi-
cates that the reduction of Fgf3 expression is not due to the loss of the Fgf3-generating cells.
Expression of Fgf15 and Fgf8 was also reduced in the Eya1-/- embryos, but unaffected in the Six1-/-
embryos (Figure 2—figure supplement 1B–1G). In contrast, the expression of Fgfr1 was neither
affected in the Eya1-/- nor in the Six1-/- embryos (Figure 2—figure supplement 1H–1J). We also
examined the expression of Spry1 (Sprouty1), a downstream effector of Fgf signaling
(Minowada et al., 1999). Spry1 expression in the ectoderm was specifically downregulated in
Eya1-/- embryos but not in Six1-/- embryos (Figure 2P–2R’), indicating a reduced level of ectodermal
Fgf signaling activity in Eya1-/- embryos. This is likely to stem from the Fgf ligand side, as the level of
Fgfr1 was not affected in the mutant embryos (Figure 2—figure supplement 1H–1J). Pharyngeal
arch segmentation occurred normally in the Six1-/- embryos (Figure 2F, I, L’, O’ and and R’),
whereas it was severely compromised in the Eya1-/- embryos as described in Figure 1. Finally, epi-
branchial placodal cells in the Eya1-/- embryos did not express Neurog2 (Figure 2T and T’), while
Neurog2 expression was still observed in the petrosal and nodose placodes in the Six1-/- embryos
(Figure 2U and U’). This result verified previous findings that epibranchial placode neurogenesis was
affected in both mutants, but more severely in the Eya1-/- embryos (Zou et al., 2004).
In sum, the Eya1-/- and Six1-/- embryos differ in some important regards (Figure 2V). In the
Eya1-/- embryos, there are pharyngeal arch segmentation defects, loss of proximal arches accompa-
nied by loss of ectodermal Fgf3 and Neurog2 expression. Conversely, in the Six1-/- embryos, the
Sox2+ cells are specified and patterned in the right position and able to produce near normal levels
of Fgf3. While it is possible that other Six genes such as Six2/4 may compensate for the absence of
Six1, collectively, the data suggest that Eya1 is specifically required to regulate the formation of PA
and epibranchial placodes.
Bipotential epibranchial placode differentiation
To gain insights into the cellular origin of the Eya1-/- specific phenotypes, we analyzed Sox2, Fgf3
and Neurog2 expression during epibranchial placode and PA development. The expression patterns
and morphological transitions are summarized in Figure 3 and Figure 3—figure supplement 1. To
obtain a more high-resolution view of the gene expression patterns, we examined the expression of
Eya1, Sox2, Neurog2 and Fgf3 on transverse sections from E8.0 (5 somites) to E9.5 (25 somites) wild-
type embryos at the position of the epibranchial or geniculate placodes. At E8.0 (5ss), the thickened
placodal ectoderm was Sox2+ and none of the cells was Fgf3+ or Neurog2+ (Figure 3A and F–G’).
At E8.5 (8ss), Neurog2 and Fgf3 expression started to emerge in the Sox2+ placodal ectoderm
(Figure 3B and I–J’). Co-staining for Sox2 and Neurog2 showed a salt-and-pepper expression distri-
bution at 15ss (Figure 3L) and three types of expression patterns could be discerned: Sox2 single
positive, Neurog2 single positive, and Sox2/Neurog2 double positive cells. Fgf3 expression could
also be detected in the Sox2+ cell population (Figure 3C and M–M’). At 8-15ss, there were Fgf3/
Sox2 double positive cells in the Neurog2 positive region (Figure 3I–3J’ and and L–M’). Interest-
ingly, at E9.5 (25ss), all Neurog2+ cells were sorted to the proximal region while the Sox2+/Fgf3+
cells were confined to the more distal region on the lateral surface of the PA (Figure 3O–3P’). Eya1
was co-expressed with Sox2 from 5ss onwards and was expressed in both the Neurog2+ and Fgf3+
regions from 8 to 25ss (Figure 3E, H, K and N). Since the Fgf3+/Sox2+/Neurog2- cells also exhibited
a thickened epithelial morphology and expressed Eya1, we propose that these cells define a new
non-neuronal cell lineage in the epibranchial placode. In Eya1-/- embryos, Neurog2 expression was
lost while Sox2 expression was still retained in the epithelium from E8.0 to E9.5 (Figure 3—figure
supplement 1A–1D’). Therefore, while the Neurog2+ neurogenic placodal cells were lost, the Sox2+
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Figure 3. Bipotential Sox2+ progenitors give rise to both neurogenic and non-neuronal epibranchial placodal cells. (A–D) Sox2, Fgf3 and Neurog2
expression in whole-mount WT embryos at E8.0, E8.5, E8.75 and E9.5. At E8.0, the pharyngeal surface ectoderm was induced to form the thickened
posterior placode, which expressed Sox2 but not Fgf3 or Neurog2 (A). At E8.5, the first PA became morphologically identifiable and the pharyngeal
ectoderm began to make contact with the endoderm. Fgf3 and Neurog2 expression could be detected in the epibranchial placode (B). At E8.75, the
Figure 3 continued on next page
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cells in the non-neuronal lineage remained in the Eya1-/- embryos (depicted in Figure 3—figure sup-
plement 1E).
We next asked whether the Neurog2+ cells that delaminate to form neurons in the cranial ganglia
and the Fgf3+/Sox2+/Neurog2- cells were lineage-related. To address this, we used a Sox2 cell line-
age tracing system (Sox2-CreER; R26REYFP mice) in which tamoxifen induction at E7.5 would label
the Sox2-expressing cells after this stage. Analysis of tamoxifen-injected embryos two days later, at
E9.5 (Figure 3Q), revealed that some EYFP-expressing cells were also positive for Islet1, a marker
for delaminating neurons (Figure 3R), suggesting that the Sox2+ lineage gave rise to neuronal prog-
eny destined for the geniculate ganglion. We however also observed EYFP-expression in cells with
thickened epithelial morphology, which expressed Sox2 and also gave rise to the pharyngeal cleft,
and proximal pharyngeal ectoderm cells (Figure 3—figure supplement 3S). This indicates that cells
expressing Sox2 at E7.5 segregated to delaminating neurons as well as to cells in the non-neuro-
genic lineage. In conclusion, these data provide evidence for a novel type of lineage that ‘lives on’ in
the epibranchial placode after delamination of neuronal cells, and continues to express Sox2, Fgf3
and other factors. By injection of tamoxifen at E9.5 and analysis at E12.5 and E14.5, we detected
EYFP expression in the external auditory canal and pinna epithelium, indicating that non-neuronal
cells were produced (Figure 3—figure supplement 1H and I). The segregation of Sox2, Neurog2
and Fgf3 expression from E8.0–9.5 leading to the genesis of delaminating neuroblasts and the non-
neuronal lineage are schematically depicted in Figure 3U.
Notch signaling is reduced in the pharyngeal epithelium of Eya1-/-
embryos
The Notch signaling pathway is a key regulator of the neurogenesis of cranial placodes and cell fate
specification (Hartman et al., 2010; Lassiter et al., 2014). We first analyzed the distribution of com-
ponents of the Notch pathway and downstream target genes in wildtype embryos. The pharyngeal
ectoderm showed extensive co-expression of Notch1 with Eya1 (Figure 4—figure supplement 1A–
1A’’) and Sox2 from E8.0 onwards (Figure 4—figure supplement 1O and Q). Notch immunoreactiv-
ity was observed also in the nuclei, indicating active Notch signaling, a notion further supported by
expression of Hey1, a Notch downstream target, at the pharyngeal ectoderm, with a distribution
similar to that of Sox2 from E8.5 to E9.5 (Figure 4—figure supplement 1B–1E). In contrast, the
expression domain of the Notch ligand Delta-like1 (Dll1) was found to overlap with that of Neurog2
from E8.5 to E9.5 (Figure 4—figure supplement 1F–1I). The expression domain of the Jag1 (Jag-
ged1) ligand was broader, extended across both the Neurog2+ and Fgf3+ regions (Figure 4—figure
supplement 1J–M). In sum, this indicates that Notch signaling pathway is involved in the specifica-
tion of both the neurogenic and non-neuronal epibranchial domains.
We next assessed whether Notch signaling was altered in Eya1-/- E9.5 embryos. To identify acti-
vated Notch signaling, we used an antibody that specifically recognizes the nascent N-terminus
Figure 3 continued
first pharyngeal cleft was already visible on the lateral side of the embryo, just rostral to the group of Sox2+cells, and Fgf3 and Neurog2 expression
expanded ventrally and dorsally, respectively (C). At E9.5, the Sox2 and Fgf3 signals became more condensed and restricted to the rostral-proximal PA,
while the Neurog2 expression expanded more dorsally in each PA (D), and the separation of the Sox2+/Fgf3+ and Neurog2+ cells became clear. Arrows
indicate Sox2-expressing epibranchial placodal regions (n  5 for each stage). Black dashed lines indicate the position of foregut dorsal endoderm. (E–
P’) Immunostaining for Eya1 (E, H, K and N) and co-immunostaining of Neurog2 and Sox2 (F, I, L and O) on adjacent transverse sections; and co-
staining of Sox2 and in situ hybridization of Fgf3 (G, J, M and P) on transverse sections of WT embryos at different somite stages (ss) as indicated.
Arrowheads indicate Neurog2+/Sox2+ double positive cells (n  4 per stage). (Q–S) Lineage tracing of Sox2+ placodal cells in Sox2-Cre; R26REYFP
embryos. Tamoxifen was injected at E7.5 and embryos examined by whole-mount EYFP fluorescence at E9.5 (n = 10) (arrowheads indicate EYFP+
placodal regions) (Q). Co-immunostaining for Islet1/EYFP and Sox2/EYFP revealed the neurogenic lineage (n = 6) (R) and non-neuronal lineages (n = 4)
(S). Arrow indicates Islet1+/EYFP+ positive cell. (T) Schematic diagram illustrating the coronal (blue; S) and transverse (pink; E–P’ and R) planes of
sections for the respective panels in this figure. (U) Schematic diagram summarizing the differentiation of Sox2+ epibranchial placode progenitors (blue)
into Neurog2+ neurogenic placodal cells and delaminating neurons (red); and Sox2+/Fgf3+ placodal cells (green). Scale bars, 100 mm.
DOI: https://doi.org/10.7554/eLife.30126.007
The following figure supplement is available for figure 3:
Figure supplement 1. Analysis of bipotential Sox2+ progenitors of the neurogenic and non-neuronal lineages in the epibranchial placodes.
DOI: https://doi.org/10.7554/eLife.30126.008
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(V1744) formed on Notch1 ICD after g-secretase cleavage. In wildtype embryos, V1744 immunoreac-
tivity was observed in the ectodermal and endodermal cells as well as in the neural crest (Figure 4A
and A’), whereas the ectodermal staining was specifically lost in the Eya1-/- embryos (Figure 4B and
B’). This result may indicate that Notch1 is not proteolytically activated or that there is a reduction in
the total amount of receptor. To distinguish between these two possibilities, we used an antibody
(C20) that recognizes an epitope internally in the Notch1 ICD and thus monitors total amount of
Notch1. The C20 immunoreactivity revealed a specific reduction of Notch1 immunoreactivity in the
rostral-proximal ectodermal cells (Figure 4D and D’) as compared to wildtype (Figure 4C and C’),
suggesting that the total amount of Notch1 receptor was reduced in the ectodermal cells rather
than that receptor cleavage was affected. By in situ hybridization, we found that Notch1 mRNA was
expressed in the ectodermal cells at E8.5 (8ss) (Figure 4—figure supplement 1S and T) and E9.5
(Figure 4—figure supplement 1U and V), while the protein expression of Notch1 was reduced from
around 8ss in the Sox2+ placodal progenitors (Figure 4—figure supplement 1O–1R’), indicating
post-transcriptional regulation of Notch1 in Eya1-/- embryos. The Notch3 receptor, which was also
expressed in the pharyngeal ectoderm, was not affected in the Eya1-/- embryos (Figure 4—figure
supplement 1X’). In wildtype embryos, Jag1 was expressed at high level at the PA segmental plate
contact points and at a lower level in the rostral-proximal ectoderm, similar expression pattern was
found in Eya1-/- embryos despite the absence of PA segmental plates (Figure 4E and F). On the
other hand, Dll1 expression was lost in the epibranchial placode region in Eya1-/- embryos
(Figure 4G and H). The downregulation of total amount of Notch1 protein was confirmed by West-
ern blot analysis of dissected pharyngeal regions from E9.5 Eya1-/- embryos, and Eya1 protein levels
were as expected non-detectable (Figure 4M). In keeping with reduced Notch1 receptor levels,
expression of Hey1 was significantly downregulated in the ectoderm in the Eya1-/- E9.5 embryos
(Figure 4I and J). Expression of Hes1, however, was much less affected (Figure 4K and L), which is
consistent with that substantial Hes1 expression was observed in RBPJ-/- embryos (de la Pompa
et al., 1997), suggesting that Hes1 is also regulated by other factors. Taken together, the results
indicate that Eya1 is required for maintaining a normal level of Notch1 protein and for controlling
the Notch signaling level in the ectodermal epithelium of PA2.
Expression of Notch1 ICD rescues the non-neuronal epibranchial
lineage and pharyngeal arch segmentation phenotype in Eya1-/-
embryos
As loss of Eya1 resulted in reduced levels of the Notch1 receptor and lower expression of Notch
downstream genes in the pharyngeal ectoderm, we next sought to explore whether restoring Notch
signaling could override the phenotypic consequences of Eya1-deficiency. In a genetic rescue experi-
ment, we deployed activation of Notch1 ICD in the pharyngeal ectoderm from the Rosa26N1-IC
mouse (Murtaugh et al., 2003) by Pax2-Cre activation (Ohyama and Groves, 2004). Cre activity
and ectopic Notch1 ICD expression were revealed by EYFP and GFP staining, respectively
(Figure 5A and C), and were both observed in the pharyngeal ectoderm (Figure 5B and D). A defin-
itive first pharyngeal cleft could be found in the Pax2-Cre; Rosa26N1-IC; Eya1-/- embryos (Figure 5F),
compared with the defective pharyngeal cleft in Eya1-/-embryos (Figure 1C). Expression of Hey1
confirmed the upregulation of Notch signaling in the Pax2-Cre; Rosa26N1-IC and Pax2-Cre;
Rosa26N1-IC; Eya1-/- embryos (Figure 5—figure supplement 1C and D). To corroborate the restora-
tion of pharyngeal cleft by elevating Notch signaling, we used two other Cre drivers (B2-r4-Cre and
Sox2-CreER) (Szeto et al., 2009; Arnold et al., 2011) to express Notch1 ICD, and in both cases the
pharyngeal segmentation phenotype was restored in Eya1-/- embryos (Figure 5—figure supplement
1G–J). The difference between the different Cre drivers is likely attributed to slight spatial differen-
ces in the Cre activity from the different regulatory elements (Figure 5—figure supplement 1K–V).
Moreover, expression of Notch1 ICD from the Pax2-Cre driver in a wildtype background, i.e. elevat-
ing Notch signaling above the normal level rather than restoring reduced Notch signaling, did not
affect the normal pharyngeal cleft formation (Figure 5E).
To analyze the rescued phenotype in further detail, immunostaining of E-cadherin to mark the
epithelium showed that in E9.5 compound mutants the pharyngeal ectoderm and endoderm made
contacts and proper pharyngeal arch segmentation took place (Figure 5J). Brn1 expression was also
restored in the maxillary-mandibular junction of PA1 and proximal PA2 in Pax2-Cre; Rosa26N1-IC;
Eya1-/- embryos (Figure 5N and N’). An increased number of Sox2+ progenitors could be observed
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Figure 4. Downregulated Notch signaling in the ectoderm-derived pharyngeal epithelium of Eya1-/- embryos. (A–D and A’–D’) Immunostaining for
Notch1 ICD by V1744, which specifically recognizes Notch1 ICD (A–B’); or by C20, which recognizes an internal epitope on Notch1 ICD and thus both
cleaved and uncleaved Notch1 receptor (C–D’) on coronal sections of WT and Eya1-/- embryos at E9.5 (n = 4). Arrowheads indicate the rostral-proximal
pharyngeal ectoderm in (A-D), which are magnified in (A’-D’). (E–L) Immunostaining for Jag1 (E, F) and in situ hybridization of Dll1, Hey1 and Hes1 (G–
L) on whole-mount or coronal sections of WT and Eya1-/- embryos at E9.5 (n  4). (M) Western blot analysis of tissue extracts from proximal PA2 and
PA3 of WT and Eya1-/- embryos at E9.5 with the indicated antibodies. The red box in the embryo diagram indicates the dissected region. The Notch1
(C20) antibody recognizes both the full-length Notch1 receptor (Notch1 FL) and cleaved Notch1, which represents both the NEXT and ICD forms of the
Notch1 receptor. One representative western blot of five. Scale bars, 100 mm.
DOI: https://doi.org/10.7554/eLife.30126.009
The following figure supplements are available for figure 4:
Figure supplement 1. Expression of Notch signaling factors in the ectoderm-derived pharyngeal epithelium of WT and Eya1-/- embryos.
DOI: https://doi.org/10.7554/eLife.30126.010
Figure supplement 2. Complete western blots for Figure 4M.
DOI: https://doi.org/10.7554/eLife.30126.011
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Figure 5. Over-expression of Notch1 ICD restores pharyngeal segmentation and Fgf3 expression in the pharyngeal epithelium of Eya1-/- embryos. (A–
D) Whole mount fluorescence and section immunostaining for EYFP in Pax2-Cre; R26REYFP (A, B) and GFP in Pax2-Cre;RosaN1-IC (C, D) at E9.5, to
visualize Cre efficiency and expression of ectopic Notch1 ICD, respectively (n = 3). (E and F) Lateral view of Pax2-Cre; RosaN1-IC and Pax2-Cre; RosaN1-IC;
Eya1-/- whole-mount embryos at E9.5 (n = 5). (G–Z) Expression of for E-cadherin (G–J), Brn1 (K–N’), Sox2 (O–R’), Fgf3 (S–V’), and Neurog2 (W–Z) on
Figure 5 continued on next page
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in the entire ectodermal epithelium of PA2 of the Pax2-Cre; Rosa26N1-IC and Pax2-Cre; Rosa26N1-IC;
Eya1-/- (Figure 5R and R’). Furthermore, Pax2-Cre mediated Notch1 ICD expression rescued the
expression of Fgf3 at E9.5 (Figure 5V and V’). The reduced expression of Spry1 in the Eya1-/-
embryos (Figure 2Q) was restored upon Notch1 ICD expression (Figure 5—figure supplement 1E
and F), further supporting that Fgf signaling is regulated by Notch. Importantly, however, Neurog2
expression was inhibited by Notch1 ICD expression (Figure 5Y and Z), which is in keeping with a
role for high Notch signaling in blocking neuronal differentiation in cranial placodes (Lassiter et al.,
2014). Collectively, the results indicate that induced Notch signaling can restore Fgf downstream
signaling, rescue the morphological and functional defects of pharyngeal epithelium caused by loss
of Eya1 and that Notch signaling is sufficient to promote the formation of the non-neurogenic epi-
branchial cell population.
Eya1 dephosphorylates Notch1 ICD leading to enhanced Notch1 ICD
stability
To address the link between Eya1 and the level of Notch1 receptor, we first assessed the interac-
tions between Eya1 and Notch1 ICD proteins in transfected 293T cells. Co-immunoprecipitation (Co-
IP) experiments revealed an interaction between Flag-Eya1 and Myc-Notch1 ICD (Figure 6A), and
the C-terminal domain of Eya1 showed a strong interaction with Myc-Notch1 ICD while the N-termi-
nal domain exhibited a very weak or no interaction (Figure 6B). Furthermore, co-transfected cells
with a constant amount of Myc-Notch1 ICD and increasing amounts of Flag-Eya1 showed that the
amount of Notch1 ICD was elevated proportionally to the increase in the amount of Eya1
(Figure 6C), suggesting that Eya1 enhances the stability of Notch1 ICD. We also observed increased
amounts of full length Notch1 receptor and a membrane-tethered form mimicking an ADAM-proc-
essed Notch1 receptor (Notch1DE) in response to Eya1 in cells that were treated with g-secretase
inhibitor (DAPT) to block S3-mediated cleavage of the receptor (Figure 6D). To assess the half-life
of Notch1 ICD, we blocked protein synthesis by cycloheximide, and the short half-life of Notch1 ICD
(approximately 5 hr), which is in keeping with previous reports (Gustafsson et al., 2005), was signifi-
cantly extended (more than 10 hr) when Eya1 was co-transfected (Figure 6E and F).
Eya1 contains both a tyrosine and a threonine phosphatase activity that co-localize in the C-termi-
nal domain (Li et al., 2017), and to explore which activity was linked to Notch1, we analyzed the
effects of Eya1 mutations that abolish phosphatase activity. In contrast to the prolongation of
Notch1 ICD half-life by wildtype Eya1, two Eya1 mutants DYY and Y4, which largely affect the threo-
nine phosphatase activity (Okabe et al., 2009) did not stabilize Notch1 ICD (Figure 6E and F) and
this was the case also for Eya1D327N, which affects both the tyrosine and threonine phosphatase
activities (Li et al., 2017). To corroborate the notion that the Eya1 threonine phosphatase activity
was involved, we explored whether the amount of threonine-, serine- or tyrosine-phosphorylation of
Notch1 ICD was altered by Eya1. Analysis using anti-phosphopeptide-specific antibodies for threo-
nine, serine and tyrosine revealed that in the presence of Eya1, the total amount of Notch1 ICD was
increased but the amount of threonine-phosphorylated Notch1 ICD was reduced (Figure 6G). In
contrast, the serine-phosphorylated Notch1 ICD was not affected (Figure 6—figure supplement
1B), and tyrosine-phosphorylated Notch ICD was hardly detected (Figure 6—figure supplement
1C). In keeping with these data, in vitro phosphatase experiments, using purified Flag-Eya1 and
Flag-Notch1 ICD (Figure 6—figure supplement 1A), showed that in the presence of Eya1 the
amount of threonine-phosphorylated Notch1 ICD was reduced (Figure 6H). As the stability of
Notch1 ICD is regulated by phosphorylation and ubiquitination, in particular by the E3 ubiquitin
Figure 5 continued
whole-mount or coronal sections of WT, Eya1-/-, Pax2-Cre; RosaN1-IC and Pax2-Cre; RosaN1-IC; Eya1-/- embryos at E9.5 (n  3). Open arrowheads indicate
positions of the pharyngeal clefts. Arrowheads indicate the rostral-proximal pharyngeal ectodermal cells. Scale bars, 100 mm.
DOI: https://doi.org/10.7554/eLife.30126.012
The following figure supplement is available for figure 5:
Figure supplement 1. Over-expression of Notch1 ICD by Pax2-Cre, B2-r4-Cre and Sox2-CreER restored pharyngeal segmentation and morphogenesis
in Eya1-/- embryos.
DOI: https://doi.org/10.7554/eLife.30126.013
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Figure 6. Eya1 stabilizes and dephosphorylates Notch1 ICD. (A) Co-immunoprecipitation (Co-IP) analysis using 293T cells with (+) or without (-)
transfected Myc-Notch1 ICD and Flag-Eya1, as indicated (n = 6). Pull-down assays (IP) using anti-Flag or anti-Myc antibodies. Western blot analyses (IB)
using anti-Myc or anti-Flag antibodies. Input was 5% of the amount of proteins used for IP. (B) IP analysis using 293T cells transfected with Myc-Notch1
ICD, full-length Eya1, the N- or C-terminal portions of Eya1 (Eya1N and Eya1C, respectively) (n = 3). Input was 5% of the amount of proteins used for IP.
(C) Increased amount of Flag-Eya1 was transfected into 293T cells with control or Myc-Notch1 ICD, leading to increased level of Notch1 ICD at higher
amounts of Eya1. a-tubulin was used as internal control (n = 3). (D) Western blot analysis of 293T cells transfected with different plasmids as indicated.
Cells were treated with 10 mM g-secretase inhibitor (DAPT) for 48 hr prior to harvesting (n = 4). (E) Western blot analysis of cycloheximide (CHX) treated
cells transfected with Myc-Notch1 ICD and wild-type or mutant Eya1 cDNAs at indicated time points using anti-Notch1 ICD (V1744), anti-Flag (Eya1), or
anti-a-tubulin antibodies. Eya1 has a conserved transcriptional activation domain ED and an N-terminal ED2 domain. The DYY and Y4 mutants
Figure 6 continued on next page
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ligase Fbw7 (Oberg et al., 2001), we examined the impact of Eya1 on the turnover of Notch1 ICD.
By immunoprecipitation experiments, we demonstrated that the ubiquitinated-Notch1 ICD level was
enhanced by Fbw7, but reduced significantly in the presence of Eya1 (Figure 6I). The level of ubiqui-
tination, assessed by anti-HA antibody, was also reduced by Eya1 (Figure 6I). In conclusion, the data
show that Eya1 interacts with Notch1 ICD via its C-terminal domain and that Eya1 acts as a threonine
phosphatase on Notch1 ICD, controlling its stability.
To identify the target dephosphorylated threonine residue on Notch1 ICD, we noted that there
was a sequence similarity between the region around T2122 in Notch1 ICD and the region neighbor-
ing T58 in c-Myc (Wei et al., 2005) (Figure 7A), an established target threonine residue for the Eya1
threonine phosphatase activity (Xu et al., 2014; Li et al., 2017). To test the importance of T2122 in
relation to Eya1 phosphatase activity and Notch1 ICD stability, we generated phospho-mimetic
(T2122D) and phospho-dead (T2122A) versions of Notch1 ICD, i.e. mutant versions that mimic the
phosphorylated form and which cannot be phosphorylated, respectively (Figure 7A). The phospho-
dead Notch1 ICDT2122A mutant could interact with Eya1 (Figure 7—figure supplement 1A), and its
threonine phosphorylation status was not altered by Eya1 (Figure 7B), indicating that T2122 is the
phosphorylation site targeted by Eya1. In line with this, the amount and threonine phosphorylation
of in vitro phosphorylated Notch1 ICDT2122A was largely unaffected by Eya1 (Figure 7C). The only
other candidate site for Eya1 phosphatase activity in Notch1 ICD (T2487) (Figure 7—figure supple-
ment 1B), which is also a target of Fbw7 (O’Neil et al., 2007), was not affected by Eya1 (Figure 7B
and Figure 7—figure supplement 1C) and therefore unlikely to be an in vivo target. Finally, we
assessed the performance of the phospho-mimetic and phospho-dead Notch1 ICD mutants with
regard to stability in response to Eya1. The results from the cycloheximide treatment experiments
showed that the phospho-dead Notch1 ICDT2122A was considerably more stable (half-life = 10 hr)
than control Notch1 ICD, whereas Eya1 did not significantly alter the stability of Notch1 ICDT2122A
(Figure 7D). In contrast, the phospho-mimetic Notch1 ICDT2122D mutant displayed a short half-life (5
hr), at par with control Notch1 ICD, and its half-life was not affected by Eya1 (Figure 7E). In sum,
these results show that threonine 2122 plays a crucial role in regulating Notch1 ICD stability and is
the likely target amino acid residue for the threonine phosphatase activity of Eya1.
Figure 6 continued
abolished the threonine phosphatase activity, while the D327N mutant abolished both the tyrosine- and threonine-phosphatase functions of Eya1
(n  3). (F) Summary graph showing quantification of the average Notch1 ICD protein levels relative to a-tubulin in experiments shown in (E). The
relative protein levels were normalized to time point zero, fitted with one-phase decay, and the half-life (t1/2) calculated. Error bars represent SEM.
*p<0.05. Statistical significance between two groups was determined by unpaired two-tailed Student’s t-test. (G) Western blot analysis of
phosphorylation status of Notch1 ICD. Flag-Notch1 ICD was immunoprecipitated with anti-FLAG M2 antibody with (+) or without (-) transfected Flag-
Eya1, using pT-P antibodies (anti-phospho-Threonine-Proline antibody) or anti-Flag targeting the total Notch1 ICD. Graphs show quantification of the
average levels of phosphorylated or total Notch1 ICD in the presence of control or Eya1 (n = 5). (H) Analysis of dephosphorylation of Notch1 ICD by
Eya1 by an in vitro phosphatase assay. Flag-Notch1 ICD and Flag-Eya1 purified from 293T cells were incubated in vitro, after which the phosphorylation
status of Notch1 ICD was examined by immunoblotting with anti-pT-P and anti-Flag antibodies. Graphs show quantification of the average levels of
phosphorylated or total Notch1 ICD incubated with or without Eya1 (n = 4). (G and H) Error bars represent SEM, and p values were calculated using
one sample t-test, *p<0.05. (H) Ubiquitination of Notch1 ICD was reduced in the presence of Eya1. Lysates from 293T cells transfected with indicated
plasmids were treated with 20 mM MG132 for 6 hr before lysis (n = 3). The lysate were immunoprecipitated with anti-Notch1 (C20) and immunoblotted
with anti-Notch1 ICD (V1744), anti-HA, anti-Myc and anti-Flag. Input was 5% of the amount of proteins used for IP.
DOI: https://doi.org/10.7554/eLife.30126.014
The following source data and figure supplements are available for figure 6:
Source data 1. Source data relating to Figure 6E.
DOI: https://doi.org/10.7554/eLife.30126.017
Source data 2. Source data relating to Figure 6F.
DOI: https://doi.org/10.7554/eLife.30126.018
Source data 3. Source data relating to Figure 6G.
DOI: https://doi.org/10.7554/eLife.30126.019
Figure supplement 1. Eya1 does not affect serine or tyrosine phosphorylation level of Notch1 ICD.
DOI: https://doi.org/10.7554/eLife.30126.015
Figure supplement 2. Complete western blots for Figure 6 and Figure 6—figure supplement 1.
DOI: https://doi.org/10.7554/eLife.30126.016
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Figure 7. Eya1 targets the T2122 phosphorylation site of Notch1 ICD. (A) Schematic diagram showing Notch1 ICD protein domains. Alignment of
Notch1 ICD peptide sequence (from a.a. 2119) with c-Myc (from a.a. 55), positions of the phospho-dead (T2122A) and phospho-mimic (T2122D)
mutations are indicated. Abbreviations: RAM, Rbp-associated molecule domain; ANK, ankyrin repeat domain; TAD, transcription activation domain;
PEST, domain rich in proline, glutamic acid, serine and threonine. (B) Phosphorylation analysis of WT Notch1 ICD, Notch1 ICDT2122A, and Notch1
Figure 7 continued on next page
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Discussion
In this study, we have uncovered the presence of groups of non-neuronal placodal cells among the
epibranchial placodes. We show that a common Sox2+ cell population produces both delaminating
neurons and a novel non-neuronal placodal cell population important for PA development and archi-
tecture. To investigate the molecular basis of epibranchial placode cell fate decisions, we have iden-
tified Notch1 ICD as a novel substrate for Eya1 phosphatase. The choice whether to become a
neuronal or non-neuronal cell is regulated by Eya1 and Notch, where Eya1 acts upstream of Notch
via its threonine phosphatase function (summarized in Figure 8).
The discovery of a non-neuronal epibranchial cell population reveals a
bipotential differentiation program in epibranchial placodes
The epibranchial placodes delaminate cells that migrate and undergo neuronal differentiation, pro-
viding sensory neurons for cranial nerves VII, IX and X. The epibranchial placodes, along with the tri-
geminal placode, are called neurogenic placodes and are distinct from other placodes, such as the
olfactory and otic placodes, which generate both neurons and non-neuronal supporting cells
(Beites et al., 2005; Patthey et al., 2014). Previous findings in chick reveal that Sox3 not only marks
the classically-defined epibranchial placodes but also a larger domain that ceases to produce neu-
rons (Ishii et al., 2001; Abu-Elmagd et al., 2001; Tripathi et al., 2009). In this report, we provide
evidence that the epibranchial placodes generate two lineage-related cell types from a common
Sox2-expressing progenitor cell pool present at around E8.0. These cells undergo a stepwise differ-
entiation and segregation into two cell types: the previously characterized Neurog2+ delaminating
neurons (Fode et al., 1998) as well as Sox2+ and Fgf3+ non-neuronal cells. The segregation to the
neuronal and non-neuronal fates appears to be gradual. At E8.5, the placodal progenitors have
already initiated the expression of Sox2, Fgf3, and Neurog2. Half a day later, the Sox2 single posi-
tive, Neurog2 single positive, and Sox2-Neurog2 double positive placodal progenitors are distrib-
uted in a salt and pepper pattern, implying that these cells may undergo a specification and
differentiation process but are still intermingled. The Neurog2+ population goes on to form the
delaminating neurons, also taking on Islet1 expression and clusters separately from the non-neuronal
progenitors (summarized in Figure 3U). This new bipotential model for epibranchial placode differ-
entiation makes the epibranchial placode more similar to other cranial placodes, which seed both
neuronal and supporting non-neuronal cells, such as the olfactory placodes. The findings also have
an evolutionary bearing, and not only reveal a similarity to the chick epibranchial placode as
Figure 7 continued
ICDT2487A by Eya1 phosphatase (n  3). Notch1 ICD was immunoprecipitated with anti-FLAG M2 antibody and analyzed by immunoblotting with anti-
pT-P and anti-Flag antibodies. Graphs show quantification of the average levels of phosphorylated or total Notch1 ICD, Notch1 ICDT2122A and Notch1
ICDT2487A in the presence of control or Eya1. Statistical significance between two groups was determined by one sample t-test. Error bars represent
SEM. ***p<0.001; *p<0.05; ns, not significant. (C) In vitro phosphatase treatment of Notch1 ICDT2122A by Eya1. Flag-T2122A and Flag-Eya1 purified from
293T cells were incubated in vitro, and then examined by immunoblotting with anti-pT-P and anti-Flag antibodies (n = 3). (D and E) Mutant Notch1 ICD
protein stability analysis (n = 3). 293T cells transfected with indicated plasmids were treated with CHX. At indicated time points, cells were lysed and
examined by immunoblotting with anti-Notch1 ICD (V1744), anti-Flag, or anti-a-tubulin antibodies. Graphs show quantification of the average Notch1
ICDT2122A or Notch1 ICDT2122D expression levels relative to a-tubulin. The relative protein levels were normalized to time point zero. No significance
was observed between the groups transfected with control or Eya1 using unpaired two-tail t-test. Error bars represent SEM.
DOI: https://doi.org/10.7554/eLife.30126.020
The following source data and figure supplements are available for figure 7:
Source data 1. Source data relating to Figure 7B.
DOI: https://doi.org/10.7554/eLife.30126.023
Source data 2. Source data relating to Figure 7D.
DOI: https://doi.org/10.7554/eLife.30126.024
Source data 3. Source data relating to Figure 7E.
DOI: https://doi.org/10.7554/eLife.30126.025
Figure supplement 1. Eya1 does not affect the T2487 phosphorylation site of Notch1 ICD, related to Figure 7.
DOI: https://doi.org/10.7554/eLife.30126.021
Figure supplement 2. Complete western blots for Figure 7 and Figure 7—figure supplement 1.
DOI: https://doi.org/10.7554/eLife.30126.022
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discussed above, but also to a novel placode located adjacent to the geniculate placode that was
recently discovered in the chick (O’Neill et al., 2012). This placode is also derived from Sox2+ cells
and gives rise to the mechanosensory paratympanic organ (PTO) in the chick middle ear
(O’Neill et al., 2012). The PTO will also delaminate neuronal precursors, indicating that in the chick,
a placode with a dual fate exists. The PTO is not unique to the chick but has been found in several
species of birds (Giannessi et al., 2013) and some reptiles also harbor PTO-like structures
(Neeser and von Bartheld, 2002), but these have not been reported in mammals (Giannessi et al.,
2013).
The non-neuronal epibranchial placodal cell population regulates
pharyngeal arch development
It may be asked what the function of the non-neuronal epibranchial placodal cell population is. Dif-
ferentiation of the non-neuronal epibranchial placodal cells is spared in the Six1-/- embryos, whereas
in the Eya1-/- embryos, both neuronal differentiation as well as Fgf expression in the non-neuronal
epibranchial placode are affected. Therefore, one may assume that phenotypes observed only in
Eya1-/- embryos can be attributed to consequences of derailed differentiation in the non-neuronal
lineage. It appears reasonable to assume that dysregulation of Fgf signaling downstream of Eya1
and Notch plays a role for the aberrant pharyngeal arch development, as mutations in Fgfr1, Fgf8
and Spry1 affect these processes (Trokovic et al., 2003; Trokovic et al., 2005; Trumpp et al.,
Figure 8. Model illustrating the role of Eya1 and Notch in regulating neurogenic and non-neuronal lineages
during epibranchial placode development. During PA development, the Eya1+/Sox2+ placodal progenitors
formed at E8.0 are separated into two distinct cell populations by E9.0: the Neurog2+ neurogenic cells and the
Sox2+/Fgf3+ non-neuronal cells in the proximal PA region, and with further spatial separation at E9.5. Our findings
indicate that Notch1 ICD is dephosphorylated and stabilized by Eya1. The Notch1 ICD level is critical to control
the cell fate decision for these two distinct cell populations and to regulate neurogenesis, pharyngeal
segmentation and development of proximal arches.
DOI: https://doi.org/10.7554/eLife.30126.026
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1999; Tucker et al., 1999; Abu-Issa et al., 2002; Simrick et al., 2011), but more work is required to
precisely identify which Fgf ligand is most important. Similarly, it may be reasoned that the location
of the non-neuronal placodal cells precisely where segmentation of the PA occurs would make them
suitable candidates as signaling centers for this process, but additional research is required to strin-
gently test their role in the formation of proximal PA. In addition to the geniculate placode, the
petrosal and nodose placodes also consist of Sox2+ and Fgf3+ non-neuronal placodal cells, as well
as Neurog2+ neurogenic cells (Figure 3—figure supplement 1F and G).
An Eya1-Notch axis in epibranchial placode differentiation
We provide several lines of evidence that Notch acts downstream of Eya1 in craniofacial develop-
ment. Firstly, Eya1 positively regulates Notch signaling activity during pharyngeal epithelium devel-
opment, and in the absence of Eya1, the level of Notch1 receptor as well as expression of the Notch
downstream gene Hey1 was down-regulated in the pharyngeal epithelium. Secondly, ectopic
expression of Notch1 ICD in Pax2-expressing cells was sufficient to rescue the PA phenotypes
caused by loss of Eya1. Importantly, the phenotypic rescue by Notch1 ICD expression included
restored expression of Fgf3 and Spry1 in the epibranchial surface, indicating that Notch1 ICD is suffi-
cient to activate the expression of Fgf3 and Spry1 without Eya1 in the pharyngeal ectoderm. Inter-
estingly, expressing supra-physiological levels of Notch1 ICD, as determined by the elevated levels
of Hey1 (Figure 5—figure supplement 1C and D) expression, did not generate a phenotype, which
is in contrast to other situations of hyperactivated Notch signaling, for example in acute lymphoblas-
tic T-cell leukemia (Weng et al., 2004).
Our analysis identifies specific roles for Notch signaling in the different steps of epibranchial pla-
code differentiation. We confirm previous reports that Notch signaling exerts a negative effect on
neuronal fate specification, differentiation and delamination from the epibranchial placode
(Lassiter et al., 2014) as neuronal differentiation, as judged by Neurog2 and Islet1 expression, was
largely ablated upon Notch1 ICD overexpression. In the neuronal differentiation program, which
also requires Eya1, Notch signaling needs to be turned off in order for neurons to differentiate. As
concerns the non-neuronal epibranchial cells, we define a new role for Notch in promoting the differ-
entiation of the Sox2+/ Fgf3+ cells (summarized in Figure 8). Here, Notch signaling needs to be sus-
tained by the Eya1 threonine phosphatase activity. It will be interesting to explore whether the Eya1-
Notch axis may be important also in other organs, where both Eya1 and Notch are expressed, and
in support of such a notion, it has been observed that in the developing lung epithelium of Eya1-/-
embryos, the expression of Notch1 ICD, Hes1, and Hes5 was reduced (El-Hashash et al., 2011).
Eya1 positively regulates Notch signaling via dephosphorylation of
Notch1 ICD
We provide evidence that Eya1 acts as threonine phosphatase for Notch1 ICD, and while a number
of kinases responsible for phosphorylating Notch ICDs have been identified, including CDK8,
GSK3b, NEMO, aPKC and PIM kinase (Foltz et al., 2002; Fryer et al., 2004; Ishitani et al., 2010;
Sjo¨qvist et al., 2014; Santio et al., 2016), this is to the best of our knowledge the first demonstra-
tion of a phosphatase acting on Notch ICD. Notch1 ICD interacts with the C-terminal domain of
Eya1, which harbors the threonine kinase activity (Li et al., 2017). The target site for the Eya1 threo-
nine phosphatase activity is likely to be T2122 in Notch1 ICD, as the phospho-dead Notch1
ICDT2122A mutant was not dephosphorylated by Eya1. Furthermore, the sequence composition
around T2122 in Notch is strikingly similar to a domain in Myc, which harbors a threonine residue
(T58) that is also dephosphorylated by Eya1 (Xu et al., 2014; Li et al., 2017). The notion that
dephosphorylation by Eya1 positively affects Notch1 ICD stability is supported by several lines of
evidence. Notch1 ICD half-life was considerably enhanced by the presence of Eya1 and conversely,
Eya1-/- embryos showed reduced levels of the Notch1 receptor, accompanied by reduced expression
of the Notch downstream gene Hey1. Eya1 is likely to exert an effect also on the full length Notch1
receptor, as the amount of Notch1 receptor was elevated after Eya1 stimulation under conditions
when g-secretase-mediated cleavage was blocked. Mutations in Eya1 that affect the threonine phos-
phatase activity in the C-terminal region or substrate-interacting domains in the N-terminal region
failed to prolong the half-life of Notch1 ICD. Furthermore, the phospho-dead version of Notch1 ICD
(Notch1 ICDT2122A) showed enhanced stability and was not affected by Eya1, whereas a phospho-
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mimetic mutant (Notch1 ICDT2122D) was short-lived, both in the presence and absence of Eya1 (Fig-
ure 7). Collectively, these data provide a strong correlation between the phosphorylation status at
T2122 and Notch1 ICD stability.
The identification of Eya1 as a phosphatase for T2122 raises the question of the nature of the
kinase phosphorylating this site. The sequences around T2122 in Notch1 ICD are quite similar to
sequences in Myc, cyclin E and c-Jun (Wei et al., 2005) (Figure 7—figure supplement 1B), and the
threonine residues at the positions corresponding to T2122 in Myc and c-Jun can be phosphorylated
by GSK3b (Welcker et al., 2004; Wei et al., 2005). This makes GSK3b a strong candidate as a
kinase for T2122 in Notch1 ICD and GSK3b has indeed been shown to phosphorylate Notch ICDs
(Foltz et al., 2002). The conserved domain around T2122 also constitutes a binding site for the
Fbw7 E3 ubiquitin ligase in c-Jun where phosphorylation of the corresponding threonine residue in
the c-Jun phosphodegron motif stimulates ubiquitination and proteasome-mediated degradation
(Wei et al., 2005). We therefore propose that dephosphorylation of T2122 by Eya1 leads to
decreased ubiquitination and therefore enhanced stability of Notch1 ICD.
In conclusion, our data shed new light onto the process of PA and epibranchial placode differenti-
ation by providing evidence for a non-neuronal developmental trajectory from the epibranchial plac-
odes. The non-neuronal epibranchial placodal cells are important for PA and cleft formation and link
the placodal and PA developmental processes. The data also reveal that this more complex differen-
tiation program in the epibranchial placodes is regulated by a novel Eya1-Notch axis and Notch1
ICD phosphorylation status.
Materials and methods
Key resources table
Reagent type (species)
or resource Designation Source or reference Identifiers Additional information
antibody Goat polyclonal
anti-Sox2
Neuromics (Minnesota, USA) GT15098-100,
RRID: AB_2195800
1/500, IHC
antibody Goat polyclonal
anti-Sox3
R and D systems (Minnesota, USA) AF2569,
RRID: AB_2239933
1/500, IHC
antibody Rat monoclonal
anti-Jagged1
DSHB (Iowa, USA) Ts1.15h,
RRID: AB_528317
1/300, IHC
antibody Rabbit monoclonal
anti-E-cadherin
(24E10)
Cell Signaling
Technology (Massachusetts, USA)
3195,
RRID: AB_2291471
1/1000, IHC
antibody Mouse polyclonal
anti-Eya1(A01)
Abnova (Taiwan) H00002138-A01,
RRID: AB_563241
1/300, IHC, WB
antibody Goat polyclonal
anti-Notch1 (C20)
Santa Cruz
Biotechnology (Texas, USA)
sc-6014;
RRID: AB_650336
1/400, IHC, WB, IP
antibody Rabbit polyclonal
anti-Cleaved Notch1
Abcam (Hong Kong) ab52301,
RRID: AB_881726
1/500, IHC, WB
antibody Rabbit polyclonal anti-
Cleaved Notch1 (Val1744)
Cell Signaling
Technology
2421S,
RRID: AB_2314204
1/500, IHC, WB
antibody Mouse monoclonal
anti-Notch3
BioLegend (California, USA) 130502,
RRID: AB_1227735
1/1000, IHC
antibody Mouse monoclonal anti-
Phospho-Threonine-Proline
Cell Signaling
Technology
9391S,
RRID: AB_331801
1/3000, WB
antibody Rabbit monoclonal anti-
Phospho-Serine-Proline-
Proline motif [pSPP]
Cell Signaling
Technology
Cat#14390 1/1000, WB
antibody Mouse monoclonal
anti-p-Tyrosine (PY99)
Santa Cruz
Biotechnology
sc-7020,
RRID:AB_628123
1/1000, WB
antibody Mouse monoclonal
anti-Neurog2
R and D systems MAB3314,
RRID:AB_2149520
1/1000, IHC
Continued on next page
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Continued
Reagent type (species)
or resource Designation Source or reference Identifiers Additional information
antibody Mouse polyclonal
anti-Islet1
DSHB PCRP-ISL1-1A9,
RRID:AB_2618775
1/400, IHC
antibody Rabbit polyclonal
anti-GFP
Abcam ab6556,
RRID:AB_305564
1/1000, IHC
antibody Rabbit polyclonal
anti-Hes1
Abcam ab71559,
RRID:AB_1209570
1/500, WB
antibody Rabbit polyclonal
anti-Hey1
Abcam AB22614,
RRID:AB_447195
1/500, WB
antibody Mouse monoclonal
anti-GAPDH [6C5]
Abcam Ab8245,
RRID:AB_2107448
1/10000, WB
antibody Mouse monoclonal
anti-FLAG(R) M2
Sigma-Aldrich (Missouri, USA) F1804,
RRID:AB_262044
1/500 for IP, 1/4000
for WB
antibody Rabbit monoclonal
anti-Flag
Sigma-Aldrich (Missouri, USA) F7425,
RRID:AB_439687
1/4000, WB
antibody Mouse monoclonal
anti-c-Myc (9E10)
Santa Cruz
Biotechnology
sc-40,
RRID:AB_627268
1/1000, WB
antibody Mouse monoclonal
anti-Tubulin
DSHB Cat#AA4.3-s;
RRID: AB_579793
1/5000, WB
antibody Rabbit polyclonal
anti-HA-probe
Santa Cruz
Biotechnology
sc-805,
RRID:AB_631618
1/1000, WB
antibody Donkey anti-Goat
IgG (H + L) Cross-
Adsorbed Secondary Antibody,
Alexa Fluor 488
Thermo Fisher
Scientific (Hong Kong)
A-11055,
RRID:AB_2534102
1/500, IHC
antibody Donkey anti-Rabbit
IgG (H + L) Highly Cross
-Adsorbed Secondary Antibody,
Alexa Fluor 488
Thermo Fisher
Scientific
A21206,
RRID:AB_2535792
1/500, IHC
antibody Donkey anti-Rat
IgG (H + L) Highly Cross
-Adsorbed Secondary Antibody,
Alexa Fluor 488
Thermo Fisher
Scientific
A-21208,
RRID:AB_2535794
1/500, IHC
antibody Donkey anti-Mouse
IgG (H + L) Highly Cross
-Adsorbed Secondary Antibody,
Alexa Fluor 555
Thermo Fisher
Scientific
A-31570,
RRID:AB_2536180
1/500, IHC
antibody Donkey anti-Goat
IgG (H + L) Cross
-Adsorbed Secondary Antibody,
Alexa Fluor 594
Thermo Fisher
Scientific
A-11058,
RRID:AB_2534105
1/500, IHC
antibody Donkey anti-Mouse
IgG (H + L) Highly Cross
-Adsorbed Secondary
Antibody, HRP
Thermo Fisher
Scientific
A16017,
RRID:AB_2534691
1/5000, WB
antibody Donkey anti-Rabbit
IgG (H + L) Highly Cross
-Adsorbed Secondary
Antibody, HRP
Thermo Fisher
Scientific
A16035,
RRID:AB_2534709
1/5000, WB
antibody Donkey anti-goat
HRP Conjugate
Santa Cruz
Biotechnology
sc-2020,
RRID:AB_631728
1/5000, WB
antibody Anti-Digoxigenin-AP,
Fab fragments
Roche (Germany) Cat#11093274910 1/2000, ISH
peptide, recombinant protein 3XFLAG peptide Sigma-Aldrich (Missouri, USA) Cat# F4799
chemical compound, drug X-tremeGENE 9 DNA
Transfection Reagent
Roche Cat#6365779001
chemical compound, drug Proteinase K Sigma-Aldrich (Missouri, USA) Cat#P6556
Continued on next page
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Reagent type (species)
or resource Designation Source or reference Identifiers Additional information
chemical compound, drug Cycloheximide Sigma-Aldrich (Missouri, USA) Cat#C7698
chemical compound, drug Tamoxifen Sigma-Aldrich (Wisconsin, USA) Cat#06734
chemical compound, drug Z-Leu-Leu-Leu-al Sigma-Aldrich (Wisconsin, USA) Cat#2211
chemical compound, drug g-Secretase inhibitor IX Calbiochem (California, USA) Cat#565770
chemical compound, drug PhosStop Roche Cat#04906837001
chemical compound, drug COmplete protease
inhibitor cocktail
Roche Cat#04693132001
chemical compound, drug rProtein G Agarose Invitrogen (Hong Kong) Cat#15920–010
chemical compound, drug DAPI Sigma-Aldrich (Missouri, USA) Cat# D9542
commercial assay or kit In situ Cell Death
Detection Kit, Fluorescein
Roche Cat#11684795910
cell line (Human) HEK 293T cells ATCC (Virginia, USA) CRL-3216,
RRID: CVCL_0063
strain, strain background
(C57BL/6N)
Mouse: C57BL/6N Laboratory Animal Unit
at the University of
Hong Kong
N/A
strain, strain background
(C57BL/6N)
Mouse: Sox2-CreER The Jackson Laboratory
(Arnold et al., 2011)
RRID:IMSR_JAX:017593
strain, strain background
(C57BL/6N)
Mouse: Pax2-Cre A. Grove
(Ohyama and Groves, 2004)
RRID:
MMRRC_010569-UNC
strain, strain background
(C57BL/6N)
Mouse: B2-r4-Cre K.S.E. Cheah
(Szeto et al., 2009)
RRID:MGI:3849737
strain, strain background
(C57BL/6N)
Mouse:
Rosa26N1-IC
The Jackson Laboratory
(Murtaugh et al., 2003)
RRID:IMSR_JAX:008159
strain, strain background
(C57BL/6N)
Mouse: R26REYFP The Jackson Laboratory
(Srinivas et al., 2001)
RRID:IMSR_JAX:006148
strain, strain background
(C57BL/6N)
Mouse: Eya1-/- P.X. Xu (Xu et al., 1999) RRID:MGI:3054666
strain, strain background
(C57BL/6N)
Mouse: Six1-/- P.X. Xu
(Laclef et al., 2003)
RRID:MGI:2655196
sequence-based reagent Full list of primers
for cloning in
Table 2
N/A N/A
sequence-based reagent Full list of primers
for genotyping in
Table 1
N/A N/A
recombinant DNA reagent In situ hybridization probe : Dlx5 (Liu et al., 1997) N/A
recombinant DNA reagent In situ hybridization probe : Dlx1 (Qiu et al., 1995) N/A
recombinant DNA reagent In situ hybridization probe : Eya1 (David et al., 2001) N/A
recombinant DNA reagent In situ hybridization probe : Six1 (Pandur and Moody, 2000) N/A
recombinant DNA reagent In situ hybridization probe : Sox2 (De Robertis et al., 1997) N/A
recombinant DNA reagent In situ hybridization probe : Fgf8 (Crossley and Martin, 1995) N/A
recombinant DNA reagent In situ hybridization probe : Fgf3 (Wilkinson et al., 1988) N/A
recombinant DNA reagent In situ hybridization probe : Hes1 (Zheng et al., 2000) N/A
recombinant DNA reagent In situ hybridization probe: Fgfr1 Addgene (Massachusetts, USA) Cat# 14005
recombinant DNA reagent In situ hybridization probe: Crabp1 (IMAGE 2922473) N/A
recombinant DNA reagent In situ hybridization probe: Neurog2 (IMAGE 468821) N/A
transfected construct
(mouse)
pcDNA3.1+ Addgene Cat# V790-20
Continued on next page
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Reagent type (species)
or resource Designation Source or reference Identifiers Additional information
transfected construct
(mouse)
pcDNA3.1-Myc-N1ICD C.C. Hui (Toronto, Canada) N/A
transfected construct
(mouse)
pCS2+-N1DEF-Myc U. Lendahl
(Chapman et al., 2006)
N/A
transfected construct
(mouse)
pcDNA5-FRT-TO-N1FL-Myc U. Lendahl
(Chapman et al., 2006)
N/A
transfected construct
(mouse)
P3XFLAG-myc-CMV-26 Sigma-Aldrich (Missouri, USA) Cat# E6401
transfected construct
(mouse)
pCMV-3XFlag-N1ICD This paper N/A Generated by cloning
the N1ICD fragment into the
pCMV-3XFlag-Myc-26
vector between BamHI
and EcoRI sites
transfected construct
(mouse)
pCMV-3XFlag-N1ICDT2122A This paper N/A Point mutation, primers
listed in Table 2
transfected construct
(mouse)
pCMV-3XFlag-N1ICDT2122D This paper N/A Point mutation,
primers listed in
Table 2
transfected construct
(mouse)
pCMV-3XFlag-N1ICDT2487A This paper N/A Point mutation,
primers listed in
Table 2
transfected construct
(mouse)
Flag-Eya1 P.X. Xu (Li et al., 2017) N/A
transfected construct
(mouse)
HA-Eya1 P.X. Xu (Li et al., 2017) N/A
transfected construct
(mouse)
Flag-Eya1D327N P.X. Xu (Li et al., 2017) N/A
transfected construct
(mouse)
Flag-Eya1C P.X. Xu (Li et al., 2017) N/A
transfected construct
(mouse)
Flag-Eya1N P.X. Xu (Li et al., 2017) N/A
transfected construct
(mouse)
Flag-Eya1-DYY This paper N/A Point mutation,
primers listed in
Table 2
transfected construct
(mouse)
Flag-Eya1-Y4 This paper N/A Point mutation,
primers listed in
Table 2
transfected construct
(human)
pCMV-Myc CDC4 WT* Addgene Cat# 16652
transfected construct
(human)
HA-Ubiquitin Addgene Cat# 18712
software, algorithm ImageJ http://imagej.nih.gov/ij/ ImageJ,
RRID:SCR_003070
software, algorithm Prism Version 6 http://www.graphpad
.com
GraphPad Prism,
RRID:SCR_002798
Experimental animals
The following mouse lines were used in this study: wildtype C57BL/6N, Eya1-/- (Xu et al., 1999),
Six1-/- (Laclef et al., 2003), Pax2-Cre (Ohyama and Groves, 2004), B2-r4-Ccre (Szeto et al., 2009),
Sox2-CreER (Arnold et al., 2011), RosaN1-IC (Murtaugh et al., 2003) and R26REYFP (Srinivas et al.,
2001). Mice were maintained on a C57BL/6N background. Genotyping was conducted by PCR using
primers shown in Table 1. To activate the CreERT2 protein, tamoxifen (06734, Sigma-
Aldrich, Wisconsin, USA) was dissolved in corn oil and administrated by intraperitoneal injection to
pregnant females using 0.1 mg/g body weight at E7.5 (TM E7.5) and E9.5 (TM E9.5). At least five
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embryos were analysed for each genotype at each stage. All mouse experiments were approved by
the University of Hong Kong animal research ethics committee (CULATR No. 3329–14 and 3862–15).
Scanning electron microscopy
Embryos were fixed overnight at 4˚C in 2.5% glutaraldehyde in 0.1M phosphate buffer pH 7.4, dehy-
drated through a graded series of ethanol (30%, 50%, 75%, 95%, 100%), and dried with a critical-
point dryer. Embryos were mounted and coated with platinum with sputter coater before analysis
and image capturing with a Hitachi S-3400N variable pressure scanning electron microscope. At
least three embryos were analysed for each genotype.
Whole mount in situ hybridization
Mouse embryos were harvested at E8.0, E8.5, E9.0 and E9.5, and fixed in 4% paraformaldehyde
(PFA) for overnight at 4˚C. After fixation, embryos were dehydrated with a series of methanol/PBST
solution. Whole-mount in situ hybridization was performed after rehydration, proteinase K (P6556,
Sigma-Aldrich, Missouri, USA) treatment and re-fixation with 4% PFA/0.1% glutaraldehyde. Hybrid-
ization with DIG-labeled riboprobes was carried out under high stringency conditions at 60˚C. Sam-
ples were blocked with 10% blocking reagent and 20% horse serum solution, incubated overnight
with anti-Digoxigenin-alkaline phosphatase (11093274910, Roche, Germany). After washing for 24
hr, embryos were incubated with BM purple substrate until clear signal were detected. Probes for
Eya1 (David et al., 2001), Six1 (Pandur and Moody, 2000), Crabp1 (IMAGE468821), Dlx1
(Qiu et al., 1995), Dlx5 (Liu et al., 1997), Sox2 (De Robertis et al., 1997), Fgf3 (Wilkinson et al.,
1988), Fgf8 (Crossley and Martin, 1995), Fgfr1 (14005, Addgene, Massachusetts, USA), Spry1
(Minowada et al., 1999), Neurog2 (IMAGE 2922473) and Hes1 (Zheng et al., 2000) have been
described. Probes for Brn1, DLL1, Fgf15 and Hey1 were generated from C57BL/6N mouse cDNA by
PCR with primers shown in Table S2 and then subcloned into pBluescript II KS (+), which was linear-
ized and used as a template for probe synthesis using the restriction enzyme and RNA polymerase.
For sectioning of whole-mount in situ hybridization stained embryos, samples were washed in PBS,
embedded in gelatin and sectioned at 10 mm. All in situ hybridization experiments were performed
on a minimum of 5 embryos for each genotype and for each probe.
TUNEL assay
TUNEL (terminal deoxynucleotidyl transferase-mediated dUTP-biotin nick end labeling) assay was
performed to detect cells under apoptosis. Embryos were harvested, fixed, embedded in paraffin
and sectioned. After antigen retrieval, sections were incubated with TUNEL reaction mix 1:10 (In situ
Cell Death Detection Kit, 11684795910, Fluorescein, Roche) at 37˚C for 30 min. The sections were
then washed in PBS at room temperature for 3 times and 5 min each, mounted and images captured
using an Olympus fluorescence microscope (BX51). Apoptotic cells were counted blind on three sec-
tions per embryo (n = 6). Analysis of variance was performed and significance was estimated using
Student’s t-test.
Histology and immunohistochemistry
Mouse embryo samples were fixed in 4% PFA overnight or 1 hr 4˚C, and embedded in gelatin or
dehydrated and embedded in wax. Paraffin and cryo-sections were generated at 6mm and 10
mm, respectively, and subjected to immunohistochemistry. Paraffin section immunostaining was per-
formed using anti-Sox2 (1/500, GT15098-100, Neuromics, Minnesota, USA), anti-Sox3 (1/500,
AF2569, R and D systems, Minnesota, USA), anti-Jagged1 (1/300, Ts1.15h, DSHB, Iowa, USA) and
anti-E-cadherin (1/1000, 3915, Cell signalling Technology, Massachusetts, USA) antibodies. Cryo-sec-
tion immunostaining was performed using anti-Eya1(1/300, H00002138-A01, Abnova, Taiwan), anti-
Sox2 (1/500, GT15098, Neuromics), anti-Notch1 (1/400, sc-6014, Santa Cruz Biotechnology, Texas,
USA), anti-Notch1 ICD (V1744) (1/500, 2421S, Cell Signaling), anti-Notch3 (1/1000, 130502,
BioLegend, California, USA), anti-Neurog2 (1/1000, MAB3314, R and D systems), anti-GFP (1/1000,
ab6556, abcam, Hong Kong) and anti-Islet1 (1/400, PCRP-ISL1-1A9, DSHB), followed by incubation
with Alexa Fluor 488 donkey anti-goat IgG (1/500, A-11055, Thermo Fisher Scientific, Hong Kong),
Alexa Fluor 488 donkey anti-rabbit IgG (1/500, A-21206, Thermo Fisher Scientific), Alexa Fluor 488
donkey anti-rat IgG (1/500, A-21208, Thermo Fisher Scientific), Alexa Fluor 555 donkey anti-mouse
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IgG (1/500, A-31570, Thermo Fisher Scientific), or Alexa Fluor 594 donkey anti-goat IgG (1/500,
A-11058, Thermo Fisher Scientific). Sections were counterstained with DAPI (D9542, Sigma-
Aldrich, Missouri, USA) prior to mounting. Sections from at least three different embryos were
stained with each antibody.
Cell transfections and DNA constructs
HEK 293T cells (CRL-3216, ATCC, Virginia, USA) were tested negative for mycoplasma contamina-
tion by using the universal mycoplasma detection kit (ATCC 30–1012K). Cells were maintained in
DMEM medium supplemented with 10% FBS at 37˚C with 5% CO2. Transient transfection of 293 T
cells was performed using X-treme 9 DNA Transfection Reagent (6365779001, Roche). The following
constructs were used for overexpression: pcDNA3.1-Myc-N1ICD (from C.C. Hui), pCS2+-N1DEF-Myc
and pcDNA5-FRT-TO-N1FL-Myc (Chapman et al., 2006), Flag-Eya1, HA-Eya1, Flag-Eya1D327N,
Flag-Eya1C and Flag-Eya1N (from P.X. Xu), Flag-Eya1-DYY, Flag-Eya1-Y4, pCMV-3XFlag-N1ICD,
pCMV-3XFlag-T2122A, pCMV-3XFlag-T2122D, pCMV-3XFlag-T2487A, pCMV-myc-Fbw7 and HA-
Ubiquitin (18712, Addgene). pCMV-3XFlag-N1ICD was generated by cloning the N1ICD fragment
into the pCMV-3XFlag-Myc-26 vector between BamHI and EcoRI sites. Flag-Eya1-DYY, Flag-Eya1-
Y4, pCMV-3XFlag-T2122A, pCMV-3XFlag-T2122D and pCMV-3XFlag-T2487A were generated by
site-directed mutagenesis and confirmed by DNA sequencing (primer sequences shown in Table 2).
Drug treatment
Transfected HEK 293T cells were cultured in normal DMEM with 10% FBS and penicillin/streptomy-
cin. Cycloheximide (C7698, Sigma-Aldrich, Missouri, USA) was added into the medium at a final con-
centration of 200 mM to stop protein synthesis for indicated time before western blot analysis. For
protein ubiquitination analysis, MG132 (2211, Sigma-Aldrich, Wisconsin, USA) was added into the
medium at 20 mM for 6 hr to stop protein degradation. To inhibit g-secretase activity, 12 hr before
transfection, DAPT (565770, Calbiochem, California, USA) was added to the medium at 10 mM. After
transfection, DAPT was added to the medium for 48 hr prior to harvesting the cells.
SDS-PAGE and western blot analysis
Cells or dissected embryo tissues were harvested with lysis buffer containing protease inhibitor
(04693132001, Roche) and phosphatase inhibitor (PhosStop, 04906837001, Roche). Cells were lysed
by incubating in lysis buffer at 4˚C for 20 min. The total protein concentration was measured by Pro-
tein BCA assay. Before SDS-PAGE, the protein lysate was denatured by boiling with SDS loading
buffer for 5 min. SDS-PAGE polyacrylamide gels of various percentages from 6% to 10% were used.
After protein transfer, the nitrocellulose membrane was blocked with 5% milk powder at room tem-
perature for 1 hr. Primary antibodies were diluted in 5% BSA solution. Antibodies for western blot
were: anti-Notch1 (1/300, sc-6014, Santa Cruz), anti-Eya1 (1/500, H00002138-A01, Abnova), anti-
Hes1 (1/500, ab71559, Abcam), anti-Hey1 (1/500, ab22614, Abcam), anti-Gapdh (1/10000, ab8245,
Abcam), anti-Notch1 1ICD (V1744) (1/500, 2421S, Cell Signaling), anti-Flag (1/4000, F7425, Sigma-
Aldrich, Missouri, USA), anti-Myc (9E10) (1/1000, sc-40, Santa Cruz), anti-a-tubulin (1/5000, AA4.3-s,
DSHB), anti-HA (1/1000, sc-805, Santa Cruz), anti-Phospho-Threonine-Proline (1/3000, 9391S, Cell
Signaling), anti-Phospho-Serine-Proline-Proline motif (1/1000, 14390, Cell Signaling), and anti-Phos-
pho-Tyrosine (1/1000, PY99, Santa Cruz). The membrane and primary antibody solution were incu-
bated at 4˚C for overnight. Then the membrane was washed and incubated with secondary
antibodies, Donkey anti-goat HRP Conjugate (1/5000, sc-2020, Santa Cruz), Donkey anti-Mouse HRP
(1/5000, A16017, Thermo Fisher), Donkey anti-Rabbit (1/5000, A16035, Thermo Fisher) with 5% BSA
at room temperature for 1 hr. After incubation and washing, the chemiluminescent substrate
(Thermo Scientific Pierce) was added and signals recorded by film or Gel Doc system (Bio-Rad).
Immunoprecipitation
For immunoprecipitation (IP) assay, transfected HEK 293T cells were lysed in lysis buffer (50 mM
Tris-HCl (pH7.4) containing 1.0% Nonidet P-40, 150 Mm NaCl, 5 mM EDTA, protease inhibitor
(04693132001, Roche) and phosphatase inhibitor (PhosStop, 04906837001, Roche), then spun and
the supernatant was collected for IP. IP analysis was performed by incubating the supernatant with
anti-Myc (9E10) (sc-40, Santa Cruz) or anti-FLAG M2 (F1804, Sigma-Aldrich, Missouri, USA)
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antibodies at 4˚C for 1 hr. Then recombinant Protein G Agarose (15920–010,
Invitrogen, Hong Kong) was added into the mixture and incubated at 4˚C for 1 hr. After incubation,
rProtein G Agarose was washed with lysis buffer three times. The precipitated proteins were col-
lected by boiling the rProtein G Agarose with loading buffer.
Protein purification
The Flag-tagged proteins were purified from transfected 293T cells using anti-FLAG M2 (F1804,
Sigma-Aldrich) antibody and rProtein G Agarose. The 293T cells were lysed in RIPA buffer with pro-
tease inhibitor (04693132001, Roche) and phosphatase inhibitor (PhosStop, 04906837001, Roche) at
4˚C for 20 min. After centrifugation at 12,000 rpm for 20 min, the supernatant was incubated with
anti-FLAG M2 antibodies and rProtein G Agarose with protease and phosphatase inhibitors at 4˚C
overnight. After incubation, the rProtein G Agarose was washed with RIPA buffer three times, and
the protein was eluted with 50 mM Tris-HCl buffer (pH 7.5) containing 150 mM NaCl, 10% glycerol
and 100 mg/ml of 3XFLAG peptide (F4799, Sigma). The eluted proteins were confirmed by the Coo-
massie staining method and were collected for in vitro phosphatase assay.
In vitro phosphatase assay
Purified Flag-Eya1 and Flag-N1ICD or Flag-T2122A were incubated in the reaction buffer (50 mM
Tris-HCl buffer (pH 7.5), 25 mM MgCl2, 0.5 mM EDTA, and 1 mM DTT) at 37˚C for 1 hr. The reaction
were stopped and analyzed on 6% SDS-PAGE. Western blot analyses were performed with the anti-
phosphopeptide-specific antibodies for threonine, serine and tyrosine and anti-FLAG antibodies.
Quatification and statistical analysis
Protein levels were estimated by ImageJ. Data were presented as means ± standard errors of the
means (SEMs). Graphs were generated and statistical analyses were performed using Prism. The rel-
ative protein level in Notch1 ICD stability assay was fitted with the one-phase decay. To quantify the
number of Sox2+ cells in the geniculate placode, green fluorescent positive cells on consecutive cor-
onal sections of E9.5 wildtype (17 ± 1 sections/embryo) and Eya1-/- embryos (7 ± 1 sections/embryo)
were counted (n = 3 embryos). Statistical significance between two groups was determined by two-
tailed Student’s t-test. Statistically significant differences are: *p<0.05, **p<0.01 and ***p<0.001.
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